Quanterix’ Simoa technology powers largest and most diverse global investigation of plasma neurofilament light’s role in dementia diagnosis
The ultra-sensitive biomarker platform evaluates plasma neurofilament light’s utility across 13 neurodegenerative disorders, Down syndrome and depression